Innovating Works

EUROPEAN VACCINE INITIATIVE

Desconocido
SENET: Strengthening international R I cooperations between China and the EU EUROPEAN VACCINE INITIATIVE EWIV participó en un H2020: H2020-SC1-BHC-2018-2020 China and the EU have a solid framework for successful collaboration aiming at tackling common global societal challenges, such as the progr...
2018-11-29 - 2021-12-31 | Financiado
ZIKAVAX: Fast track development of a Zika vaccine based on measles vector EUROPEAN VACCINE INITIATIVE EWIV tramitó un H2020: H2020-SC1-2016-2017 Zika virus is an emerging mosquito-borne flavivirus. Although already isolated in 1947, to date there are no specific treatments nor any vac...
2016-12-02 - 2020-12-31 | Financiado
FLUCOP: Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protect... EUROPEAN VACCINE INITIATIVE EWIV participó en un FP6: Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Infl...
2015-03-01 - 2020-02-29 | Financiado
EDUFLUVAC: Combinatorial immunization strategy to educate the immune system towards cross recognition and cover... EUROPEAN VACCINE INITIATIVE EWIV tramitó un FP7: As current influenza vaccines only afford limited protection against seasonal as well as pandemic influenza, and require regular updating, t...
Financiado
TRANSVAC: European Network of Vaccine Development and Research EUROPEAN VACCINE INITIATIVE EWIV tramitó un FP7: The TRANSVAC infrastructure will accelerate the pharmaceutical and clinical development of promising vaccine candidates by bringing the gap...
Financiado
OPTIMALVAC: Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation EUROPEAN VACCINE INITIATIVE EWIV tramitó un FP7: A broad-range of candidate malaria vaccines derived from diverse novel technologies have resulted from the multiple approaches being taken b...
Financiado
INYVAX: Optimisation of the development of Poverty Related Diseases PRD vaccines by a transversal approach... EUROPEAN VACCINE INITIATIVE EWIV tramitó un FP7: A number of new vaccines are being developed against Poverty-Related infectious diseases of major public health importance at a global level...
Financiado
IDEA: Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections An... EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: Worm infections are receiving increased attention due to: the wide geographic overlap in occurrence between worms and HIV, TB and malaria; t...
Financiado
PLACMALVAC: Clinical development of a VAR2CSA based placental malaria vaccine EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: Placental malaria, a special form of malaria targeting pregnant women, causes the death of 200,000 infants and 10,000 pregnant women each ye...
Financiado
FLUCOP: Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protect... EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Infl...
Financiado
MultiMalVax: A Multi Stage Malaria Vaccine EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: A highly effective malaria vaccine is a major goal of global health research and will likely require a multi-stage product. MultiMalVax will...
Financiado
BELLEROPHON: comBinig cELLular and humoral immunE RespOnses as a vaccine strategy against staPHhylOcoccus aureus... EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: Staphylococcus aureus, including Meticillin-resistant S. aureus (MRSA), is one of the most important bacterial pathogens, causing skin, woun...
Financiado
PHARVAT: Platform for the Harmonization of Vaccine Adjuvant Testing EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: Adjuvants are critical to the quality and magnitude of immune responses generated by PRD vaccines. However, vaccine development is hampered...
Financiado
IPROVE: Innovation Partnership for a Roadmap on Vaccines in Europe EUROPEAN VACCINE INITIATIVE EWIV participó en un FP7: Under the leadership of the major Europe-based vaccine industry players, IPROVE (Innovation Partnership for a Roadmap on Vaccines in Europe)...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.